Skip to content
Use caution Drug recall · FDA · Published December 23, 2014

Hospira Recalls Propofol Vials Due to Particulate Matter Hazard

Hospira Inc. recalls 126,075 vials of Propofol Injectable Emulsion due to embedded particulate matter. Check lot numbers and expiration dates immediately.

🇺🇸 FDA recall #D-0381-2015DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.375 N Field Dr · Lake Forest, IL 60045-2513
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling a specific batch of Propofol Injectable Emulsion because an embedded iron particulate was found in the neck of one vial. This recall affects 126,075 vials distributed nationwide. The record does not specify what patients or facilities should do with these vials. Read more at govinfonow.com/recall/45071-hospira-inc-recalls-propofol-injectable-emulsion-1-200-mg-20.

Source Summary by GovInfoNow · govinfonow.com/recall/45071-hospira-inc-recalls-propofol-injectable-emulsion-1-200-mg-20 · Updated October 12, 2026 · FDA enforcement record: FDA #D-0381-2015

Cite this page

“Hospira Recalls Propofol Vials Due to Particulate Matter Hazard.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45071-hospira-inc-recalls-propofol-injectable-emulsion-1-200-mg-20. Based on FDA recall #D-0381-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0381-2015%22&limit=1).

The FDA announced on Dec. 23, 2014, that Hospira Inc. voluntarily recalled Propofol Injectable Emulsion due to the presence of particulate matter. The recall affects 126,075 vials distributed nationwide.

How to tell if you have it

  • Brand: Hospira
  • Product: Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10mg/mL), 20 mL Single patient infusion vial
  • Contains Benzyl Alcohol
  • NDC: 0409-4699-30
  • Lot code: 35-844-DJ, Exp 11/01/2015

The hazard

The firm received a complaint of an embedded particulate in the neck of one vial composed primarily of iron. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls include the 2017-04-21 Hospira Infant Dextrose Injection Recall for hair particulates, the 2016-11-01 Hospira Fentanyl Injection Recall for broken ampule tips, and the 2016-08-15 Hospira DOBUTamine Injection Recall for discoloration and particulates. Other recent recalls of similar products include the 2026-07-24 American Regent Papaverine HCl Injection Recall, the 2026-07-29 Apollo Care SEMAGLUTIDE 10mg Vial Recall, and the 2026-03-24 GE Healthcare Omnipaque Injection Recall.

How to tell if you have this one

Look for Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10mg/mL), 20 mL single patient infusion vials containing Benzyl Alcohol. Check for NDC 0409-4699-30, Lot 35-844-DJ, and an expiration date of 11/01/2015.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Identify Recalled Vials

    Check your inventory for Propofol Injectable Emulsion with NDC 0409-4699-30 and Lot 35-844-DJ expiring on 11/01/2015.

  2. Contact Manufacturer

    Since the remedy is not stated in the record, contact Hospira Inc. directly for instructions on how to handle these vials.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 7 months after the firm started it.

1. Firm started the recall: Dec 23, 201412. FDA classified it Class II: Jan 27, 201523. Published in FDA’s Enforcement Report: Feb 4, 201534. FDA terminated the recall: Jul 30, 2015420142015
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

How many vials are affected by this recall?

A total of 126,075 vials are included in this recall.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0381-2015 (December 23, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0381-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA